Icariin Soft Capsules Combined With TACE as Adjuvant Therapy for HCC
In plain words A Phase 2 study of horny Goat Weed in people 18 to 80, run by Hua Li. It plans to enroll about 25 people at 1 site, none in the US.
Who it lists and where
Who the trial lists, as registered
Lists people 18 to 80. Conditions: Hepatocarcinoma.
- Age between 18 and 80 years;
- ECOG Performance Status (PS) of 0 or 1;
- Histologically or cytologically diagnosed as HCC
- Fully recovered from surgical resection or ablation prior to enrollment;
8 more inclusion criteria and the exclusion criteria are on the listing.
What it tests, as registered
Icariin Soft Capsules+TACE
Registered summary
This is a prospective, single-center, phase II study，to evaluate the efficacy and safety of icariin soft capsules combined with TACE as adjuvant therapy in hepatocellular carcinoma (HCC) patients at high risk of recurrence after resection.
Where, as registered
No US site; China (1).